2010
DOI: 10.1167/iovs.09-3880
|View full text |Cite
|
Sign up to set email alerts
|

Heterozygous Loss-of-Function Variants inCYP1B1Predispose to Primary Open-Angle Glaucoma

Abstract: Heterozygous CYP1B1 mutations with absent or reduced relative enzymatic activity can be considered a risk factor for POAG.

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
42
1

Year Published

2010
2010
2018
2018

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 51 publications
(50 citation statements)
references
References 33 publications
3
42
1
Order By: Relevance
“…To date a digenic inheritance in open-angle glaucoma has been reported in patients with mutations in both MYOC and CYP1B1. 13,39 Thus, on the basis of present knowledge, it is likely that the POAG in patient ID99168 (Table 2) is mainly due to the presence of mutations p.Q368X in MYOC and p.N203S in CYP1B1, as these have been previously confirmed to have a pathological function. 13,40 In fact, according to our experimental results, the p.Q589H in RPGRIP1 seems to be non-pathological (Table 1 (Table 2) instead, the JOAG phenotype may be due mainly to the pathological p.T806I mutation in RPGRIP1 (Table 1) as the MYOC mutation, p.Q352K, has been previously reported to be a probable benign sequence change.…”
Section: Rpgrip1 and Primary Open Angle Glaucoma L Fernández-martínezmentioning
confidence: 73%
See 2 more Smart Citations
“…To date a digenic inheritance in open-angle glaucoma has been reported in patients with mutations in both MYOC and CYP1B1. 13,39 Thus, on the basis of present knowledge, it is likely that the POAG in patient ID99168 (Table 2) is mainly due to the presence of mutations p.Q368X in MYOC and p.N203S in CYP1B1, as these have been previously confirmed to have a pathological function. 13,40 In fact, according to our experimental results, the p.Q589H in RPGRIP1 seems to be non-pathological (Table 1 (Table 2) instead, the JOAG phenotype may be due mainly to the pathological p.T806I mutation in RPGRIP1 (Table 1) as the MYOC mutation, p.Q352K, has been previously reported to be a probable benign sequence change.…”
Section: Rpgrip1 and Primary Open Angle Glaucoma L Fernández-martínezmentioning
confidence: 73%
“…Further recruitment and clinical data have been previously reported. 13,14,19 All subjects were also screened for MYOC, OPTN (data not shown), WDR36, 19 CYP1B1 13 and NTF4 14 mutations (to note that patients with mutations in one of these candidate genes were also included in the present screening study as the etiology of glaucoma is still unknown).…”
Section: Study Populationmentioning
confidence: 99%
See 1 more Smart Citation
“…Enzymatic assays indicate c.1103G4A, p.(Arg368His) has markedly reduced activity while c.685G4A, p.(Glu229Lys) is a hypomorphic allele. 33,34 There was no evidence of glaucoma or Peters anomaly in Patient 9 (Family 9, II.1) or Patient 11 (Family 11, II.1). CYP1B1 can contribute to retinoic acid synthesis in embryonic development, 35 and retinoic Table 3 Other variants lacking appropriate segregation-allele frequencies in public databases, conservation and prediction categories acid receptor signalling regulates choroid fissure closure.…”
Section: Exome and Target Region Analysismentioning
confidence: 97%
“…39 Our early observations of lack of clinical manifestations in CYP1B1/LTBP2 double carriers may be attributed to the involvement of the two genes in independent pathways of eye development and glaucoma pathogenesis. However, it is important to note that both CYP1B1 variantsp.E229K and p.R368H -lead to reduced, not abolished, enzyme activity and protein stability, 40,41 and display incomplete penetrance. 42,43 CYP1B1-LTBP2 interactions and their clinical implications need to be addressed in larger samples of double carriers of wellsupported pathogenic mutations.…”
Section: Population Genetics Of Pcg In Gypsiesmentioning
confidence: 99%